The workforce reduction would primarily include employees working on early-stage research programs and those at its gene therapy manufacturing facility located in Hopewell, New Jersey. The company plans to complete the process by Jan. 15 of next year, it said in a regulatory filing.
Read full NASCAR article on Yahoo Sports
Read all NASCAR articles